Concepedia

Reduction of Hypothalamic Vasopressinergic Hyperdrive Contributes to Clinically Relevant Behavioral and Neuroendocrine Effects of Chronic Paroxetine Treatment in a Psychopathological Rat Model

Martin E. Keck, Tobias Welt, Marianne B. Müller, Manfred Uhr, Frauke Ohl, Alexandra Wigger, Nicola Toschi, Rainer Landgraf

Neuropsychopharmacology · 2002 · 165 citations · 40 references

DOI

Concepts

References

40

Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin

Glenda E. Gillies, Elizabeth A. Linton, Philip J. Lowry · Nature · 1982 · 967 citations

, , +10

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V <sub>1b</sub> receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

Guy Griebel, Jacques Simiand, Claudine Serradeil‐Le Gal et al. · Proceedings of the National Academy of Sciences · 2002 · 462 citations · Full text

, , +17

Increased Number of Vasopressin- and Oxytocin-Expressing Neurons in the Paraventricular Nucleus of the Hypothalamus in Depression

Jan S. Purba · Archives of General Psychiatry · 1996 · 426 citations

, , +14

The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat

Paul E. Sawchenko, L. W. Swanson, Harry W.M. Steinbusch et al. · Brain Research · 1983 · 376 citations

, , +14

Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression

Astrid Zobel, Thomas Nickel, Annette Sonntag et al. · Journal of Psychiatric Research · 2001 · 356 citations

, , +13